Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2026 19:54 ET | Source: Robbins LLP

Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the SLNO Class Action

Robbins LLP is Investigating Allegations that Soleno Therapeutics(SLNO) Misled Investors Regarding the Viability and Efficacy of its Phase 3 Clinical Trial